FibroBiologics (FBLG) Interest & Investment Income (2024 - 2026)
FibroBiologics (FBLG) posted quarterly Interest & Investment Income of $15000.0 for Q2 2026, down 70.0% year-over-year from $50000.0 in Q2 2025, and down 25.0% on a QoQ basis from $20000.0 in Q1 2026.
FibroBiologics (FBLG) Interest & Investment Income (2024 - 2026) Analysis & Trends
FibroBiologics has reported Interest & Investment Income for 3 years, with the latest figure at $15000.0 in Q2 2026.
- Interest & Investment Income for Q2 2026 came in at $15000.0, down 70.0% year-over-year; the trailing twelve-month figure through Jun 2026 was $133000.0 (down 54.3% YoY), and the FY2025 annual result was $247000.0, down 1.59% from the prior year.
- Interest & Investment Income fell to $15000.0 in Q2 2026, from $20000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $99000.0 in Q1 2025 and troughed at $15000.0 in Q2 2026.
- A 3-year average of $53300.0 and a median of $56500.0 in 2024 frame the typical range for Interest & Investment Income.
- The widest annual swing landed in 2025, when Interest & Investment Income surged 153.85%; it then plunged 79.8% in 2026.
- A 3-year view of Interest & Investment Income shows it stood at $63000.0 in 2024, then sank by 60.32% to $25000.0 in 2025, then tumbled by 40.0% to $15000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $15000.0 in Q2 2026, $20000.0 in Q1 2026, and $25000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | FibroBiologics | 8.97 Mn | 8.97 Mn | - | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 73,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | 79,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 39,000.00 |